Target intelligence / Profile preview

Mesenteric lymph node immune function (MLN immune function)

Target
MLN immune function
Molecular classification
Other
01

Overview

Mesenteric lymph node immune function refers to the collective immunological activities occurring within the lymph nodes located in the mesentery, which drain the small and large intestines (Mowat, A. M., Nature Reviews Immunology, 2003). These nodes serve as critical hubs for the induction of mucosal immune responses and the maintenance of oral tolerance, filtering antigens derived from the gut lumen and coordinating the activation and trafficking of T and B lymphocytes (Girard, J. P., et al., Nature Reviews Immunology, 2012). In pathological states such as inflammatory bowel disease (IBD), the mesenteric lymph nodes become sites of chronic inflammation and aberrant immune cell priming (Danese, S., et al., Gut, 2015). While not a single molecular target, this system is the site of action for several therapeutic classes, including sphingosine-1-phosphate (S1P) receptor modulators like ozanimod that sequester lymphocytes within the nodes and integrin inhibitors like vedolizumab that disrupt the migration of activated cells from the nodes to the intestinal mucosa (Sandborn, W. J., et al., New England Journal of Medicine, 2013). Furthermore, the MLNs play a role in the systemic spread of intestinal infections and the pathogenesis of mesenteric adenitis (Helbling, R., et al., Journal of Pediatric Surgery, 2012). Understanding MLN function is essential for developing therapies that can selectively modulate gut-specific immunity without inducing systemic immunosuppression.

Other names
Mesenteric lymph node activityMLN immune responseGut-associated lymphoid tissue function
02

Mechanism of action

Modulation of lymphocyte egress via sphingosine-1-phosphate (S1P) receptors, inhibition of leukocyte trafficking via integrin antagonism, and neutralization of pro-inflammatory cytokines.

03

Biological functions

Immune responseLymphocyte traffickingAntigen presentationMucosal immunityOral tolerance
04

Disease associations

Inflammatory bowel diseaseCrohn's diseaseUlcerative colitisMesenteric lymphadenitisCeliac disease
05

Safety considerations

Increased risk of opportunistic infectionsImpaired mucosal defenseLymphopeniaPotential for reduced vaccine efficacy
06

Interacting drugs

Vedolizumab

5 more in the full profile.

07

Biomarkers

Fecal calprotectinC-reactive proteinLymphocyte subsetsMesenteric lymph node size

Beyond the preview

Go deeper on Mesenteric lymph node immune function (MLN immune function).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mesenteric lymph node immune function (MLN immune function).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call